The SeriousTraders Newsletter If you are Serious about Trading, become a SeriousTrader!™

Annovis Bio Inc. (NYSE: ANVS)

Recent Achievements Annovis Bio continues to advance its mission of developing transformative therapies for neurodegenerative disorders. The company recently announced statistically significant data from its Phase II/III Alzheimer’s study, demonstrating the potential of its lead drug candidate, buntanetap, to improve cognition in patients with early Alzheimer’s Disease (AD). Additionally, the company has released promising data … Continue reading “Annovis Bio Inc. (NYSE: ANVS)”

View Profile